You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

List of Excipients in API meloxicam


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing meloxicam

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Azurity Pharmaceuticals Inc XIFYRM meloxicam 24338-153 HYDROXYPROPYL BETADEX
Azurity Pharmaceuticals Inc XIFYRM meloxicam 24338-153 MEGLUMINE
Azurity Pharmaceuticals Inc XIFYRM meloxicam 24338-153 POVIDONE K12
Iroko Pharmaceuticals LLC VIVLODEX meloxicam 42211-205 CELLULOSE, MICROCRYSTALLINE
Iroko Pharmaceuticals LLC VIVLODEX meloxicam 42211-205 CROSCARMELLOSE SODIUM
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing meloxicam

Company Ingredient NDC Excipient
Liberty Pharmaceuticals Inc meloxicam 0440-5841 CELLULOSE, MICROCRYSTALLINE
Liberty Pharmaceuticals Inc meloxicam 0440-5841 CROSPOVIDONE
Liberty Pharmaceuticals Inc meloxicam 0440-5841 LACTOSE MONOHYDRATE
Liberty Pharmaceuticals Inc meloxicam 0440-5841 MAGNESIUM STEARATE
Liberty Pharmaceuticals Inc meloxicam 0440-5841 POVIDONE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for meloxicam

Excipient focus: ALCOHOL

Excipient focus: AMMONIA

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: ASPARTAME

Excipient focus: BETADEX SULFOBUTYL ETHER SODIUM

Excipient focus: BUTYL ALCOHOL

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: D&C YELLOW NO. 10

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: GLYCERIN

Excipient focus: HYDROXYETHYL CELLULOSE

Excipient focus: HYDROXYPROPYL BETADEX

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: MEGLUMINE

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: PIGMENT RED 5

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: POVIDONE

Excipient focus: POVIDONE K12

Excipient focus: POVIDONE K25

Excipient focus: POVIDONE K29/32

Excipient focus: POVIDONE K30

Excipient focus: POVIDONES

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SACCHARIN SODIUM

Excipient focus: SHELLAC

Excipient focus: SILICA

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM BICARBONATE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM DESOXYCHOLATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SODIUM STEARATE

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: SORBITOL

Excipient focus: STARCH, CORN

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: WATER

Excipient focus: XYLITOL

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links